Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 7th February 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Views sought on veterinary medicines containing zinc oxide
pig vet
Interested parties are being invited to provide written comment on proposals to withdraw veterinary medicines containing zinc oxide.
VMD invites opinion from interested parties

EU Member States are being invited to provide written comment on proposals to withdraw veterinary medicines containing zinc oxide.

In December 2016, the EMA’s Committee for Veterinary Medicinal Products (CVMP) concluded that the benefit/risk ratio for veterinary medicines containing zinc oxide is negative and that this class of products should be withdrawn.

But following numerous appeals from across the EU, the CVMP has been requested to re-examine this conclusion, with a final announcement expected in March.

In light of this review, the Veterinary Medicines Directorate - which represents the CVMP in the UK - is now calling on interested parties to submit relevant evidence via their proforma.

Specifically, the VMD is looking for comments relating to:

    •    the impact of product withdrawal on pig health and welfare and/or pig productivity
    •    husbandry and/or production system changes that will be necessary to mitigate this impact, and the economic cost of these changes
    •    effective alternatives to zinc oxide, either currently available or in development

The deadline for submission of responses is 11.59pm on 21 February. Submissions should be concise, written in English and limited to 2000 words, excluding references.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.